Cart
sales@molnova.com
NSC23005
CAS No. 6314-70-1
NSC23005( —— )
Catalog No. M17557 CAS No. 6314-70-1
NSC23005 sodium is a p18INK inhibitor with potently promoted hematopoietic stem cell (HSC) expansion (ED50: 5.21 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 56 | In Stock |
|
| 2MG | 33 | In Stock |
|
| 5MG | 53 | In Stock |
|
| 10MG | 85 | In Stock |
|
| 25MG | 167 | In Stock |
|
| 50MG | 263 | In Stock |
|
| 100MG | 423 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNSC23005
-
NoteResearch use only, not for human use.
-
Brief DescriptionNSC23005 sodium is a p18INK inhibitor with potently promoted hematopoietic stem cell (HSC) expansion (ED50: 5.21 nM).
-
DescriptionNSC23005 sodium is a p18INK inhibitor with potently promoted hematopoietic stem cell (HSC) expansion (ED50: 5.21 nM).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
Target5-HT Receptor
-
RecptorP18INK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number6314-70-1
-
Formula Weight283.34
-
Molecular FormulaC13H17NO4S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC1CCC(CC1)NS(=O)(=O)c1ccc(cc1)C(=O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Xie XQ, et,al. Discovery of novel INK4C small-molecule inhibitors to promote human and murine hematopoietic stem cell ex vivo expansion. Sci Rep. 2015 Dec 18;5:18115.
molnova catalog
related products
-
Tryptamine
Tryptamine is a monoamine alkaloid found in plants, fungi, and animals. It contains an indole ring structure, and is structurally similar to the amino acid tryptophan, from which it derives its name.
-
Lofepramine
Lofepramine is a potent tricyclic antidepressant that is extensively metabolized to desipramine.
-
NLX-204 hydrochlorid...
NLX-204 hydrochloride is a potent and selective ERK1/2 phosphorylation-preferring serotonin 5 HT1A receptor agonist(pKi = 10.19).NLX-204, displayed high selectivity in the SafetyScreen44 panel (including hERG channel), high solubility, metabolic stability, and Caco-2 penetration and did not block CYP3A4, CYP2D6 isoenzymes, or P-glycoprotein.
